Interestingly, ERBB2 overexpression has been implicated in androgen-resistant metastatic prostate cancers [26], suggesting a possible role for ERBB2 in the acquisition of metastatic potentials of prostate cancer cells. Here, ERBB2 is linked to Familial prostate cancer.